C N Robson
Overview
Explore the profile of C N Robson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
75
Citations
1704
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Johnson N, Bentley J, Wang L, Newell D, Robson C, Shapiro G, et al.
Br J Cancer
. 2024 Aug;
131(5):955.
PMID: 39160248
No abstract available.
2.
Hepburn A, Steele R, Veeratterapillay R, Wilson L, Kounatidou E, Barnard A, et al.
Oncogene
. 2019 May;
38(22):4425.
PMID: 31068666
The original version of this article contained an error in Fig. 5a where the colours of the labels representing the Hinge and LBD of the AR were incorrect and did...
3.
Hepburn A, Steele R, Veeratterapillay R, Wilson L, Kounatidou E, Barnard A, et al.
Oncogene
. 2019 Feb;
38(22):4412-4424.
PMID: 30742096
Stem cell characteristics have been associated with treatment resistance and poor prognosis across many cancer types. The ability to induce and regulate the pathways that sustain these characteristic hallmarks of...
4.
Enshaei A, Robson C, Edmondson R
Ann Surg Oncol
. 2015 Mar;
22(12):3970-5.
PMID: 25752894
Background: The ability to provide accurate prognostic and predictive information to patients is becoming increasingly important as clinicians enter an era of personalized medicine. For a disease as heterogeneous as...
5.
Williamson S, Mitter R, Hepburn A, Wilson L, Mantilla A, Leung H, et al.
Br J Cancer
. 2013 Jul;
109(4):950-6.
PMID: 23880823
Background: Evidence increasingly supports that prostate cancer is initiated by the malignant transformation of stem cells (SCs). Furthermore, many SC-signalling pathways are shown to be shared in prostate cancer. Therefore,...
6.
Armstrong K, Ahmad I, Kalna G, Tan S, Edwards J, Robson C, et al.
Br J Cancer
. 2011 Sep;
105(9):1362-9.
PMID: 21952621
Background: Prostate cancer (PC) represents a global health issue. Treatment for locally advanced and metastatic PC remains unsatisfactory. The androgen receptor (AR) has been validated in having a key role...
7.
Hori S, Jabbar T, Kachroo N, Vasconcelos J, Robson C, Gnanapragasam V
J Cancer Res Clin Oncol
. 2010 Apr;
137(2):235-41.
PMID: 20390426
Purpose: Primary androgen deprivation therapy (PADT) is an important treatment modality for men with localized or locally advanced prostate cancer and without bone metastasis. There is, however, a lack of...
8.
Johnson N, Bentley J, Wang L, Newell D, Robson C, Shapiro G, et al.
Br J Cancer
. 2009 Dec;
102(2):342-50.
PMID: 20010939
Background: Cellular proliferation, driven by cyclin-dependent kinases (CDKs) and their cyclin partners, is deregulated in cancer. Anti-estrogens, such as tamoxifen, antagonise estrogen-induced ERalpha transactivation of cyclin D1, resulting in reduced...
9.
Darby S, Murphy T, Thomas H, Robson C, Leung H, Mathers M, et al.
Br J Cancer
. 2009 Nov;
101(11):1891-9.
PMID: 19888221
Background: The fibroblast growth factor (FGF) axis is an important mitogenic stimulus in prostate carcinogenesis. We have previously reported that transcript level of human similar expression to FGF (hSef), a...
10.
Sheach L, Adeney E, Kucukmetin A, Wilkinson S, Fisher A, Elattar A, et al.
Br J Cancer
. 2009 Jul;
101(3):498-503.
PMID: 19623182
Background: Epidemiological and in vitro data implicate androgens in the aetiology of ovarian cancer, but the mechanisms by which this is mediated are unclear. In this study, we wished to...